HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

Rhythm Pharmaceuticals, Inc. announced today the results from a proof-of-concept, Phase 1b clinical trial assessing the safety and efficacy of setmelanotide (RM-493), the company's novel...

Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced the presentation of clinical data featuring the use of its Precision Cancer MonitoringSM (PCM) platform...

Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) today announced that top-line renal results from the EMPA-REG OUTCOME® study (compound empagliflozin,...

Functional Neuromodulation Ltd. announced that an analysis of the ADvance Study, a Phase 2 double-blind randomized controlled trial of DBSf for mild Alzheimer's disease (clinicaltrials.gov...

CareFusion, a BD company (NYSE:BDX), will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or breathing on their own, at the American Association...

Zipongo, the digital health company that makes it easy to eat well, announced that CEO Jason Langheier, MD, MPH has been invited to speak Saturday, Nov. 7 at reTHINKFood, a conference for leaders...

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the following investor conferences: 24th Annual...

Nomad Foods Limited (LSE: NHL) ("Nomad") announced today that it will be presenting at the Morgan Stanley Global Consumer and Retail Conference on Tuesday, November 17, 2015 at 4:20 p.m. ET. An...

CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today announced that data highlighting two compounds (pacritinib and tosedostat) from the company's investigational pipeline will be presented at...